Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
A recent manufacturer-backed pill launch is set to retail substantially lower than injectables, with introductory pricing quoted around $149 per month for starter dosing through direct channels
You can tell they all get along and have a great work culture
The SURMOUNT trial program, which is the largest clinical trial series evaluating tirzepatide for obesity, has produced results that have reshaped how clinicians think about medically supervised weight loss
However, regulatory approval is still pending, and further long-term data are required
Plans should take into account the likelihood of approval if non-formulary, considering the limited alternative options for this indication and mechanism of action
